AT THE FOREFRONT OF 

CRISPR THERAPEUTICS DEVELOPMENT

A NOVEL CRISPR TECHNOLOGY

Directly addressing the inherent limitations of current CRISPR methodologies, we seek to unlock previously unattainable avenues in the development of CRISPR based therapeutics.

TECHNOLOGICAL FEATURES

Unprecedented

Corrective

Repair Rates

Safety from

off-target  

and

Immunogenicity

Unique

RNP Delivery

Highly Efficient 

Cellular Delivery

"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
 

PROF. GEORGE CHURCH, CRISPR PIONEER

FIND OUT MORE.

CONTACT US.

AddressIn

Institut NEOMED

7171 Frederick Banting
Saint-Laurent  H4S 1Z9

(Québec) Canada

Email

laurent.ziri@jenthera.com

 

    ©2021 Jenthera Therapeutics.  All Rights Reserved.